Invention Grant
- Patent Title: Nucleic acid molecules encoding muteins of human tear lipocalin which bind PCSK9
-
Application No.: US14839222Application Date: 2015-08-28
-
Publication No.: US09598476B2Publication Date: 2017-03-21
- Inventor: Gabriele Matschiner , Christine Rothe , Andreas Hohlbaum , Andrea Allersdorfer , Rachida Siham Bel Aiba , Marlon Hinner , Alexander Wiedenmann , Bradley Lunde , Shinji Yamaguchi , Takahide Aburatani , Ryuji Hashimoto , Tohru Takahashi , Chikako Nagasaki , Futoshi Nara , Tomohiro Nishizawa
- Applicant: Daiichi Sankyo Co., Ltd.
- Applicant Address: JP Tokyo
- Assignee: Daiichi Sankyo Co., Ltd.
- Current Assignee: Daiichi Sankyo Co., Ltd.
- Current Assignee Address: JP Tokyo
- Agency: Foley & Lardner LLP
- Priority: EP13175023 20130704
- Main IPC: C07K14/47
- IPC: C07K14/47 ; G01N33/573 ; A61K39/00 ; C07K14/435
Abstract:
The present disclosure relates to novel lipocalin muteins which bind to PCSK9. The disclosure also provides corresponding nucleic acid molecules encoding lipocalin muteins and methods for producing lipocalin muteins as well as their encoding nucleic acid molecules.
Public/Granted literature
- US20160024161A1 NOVEL BINDING PROTEINS FOR PCSK9 Public/Granted day:2016-01-28
Information query
